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http://dxObjective:We evaluated the results of our previous study investigating a precurved fenestrated endograft treat-
ment for thoracic aortic aneurysms and aortic dissection extended to the aortic arch.
Methods: From February 2010 to December 2011 at 35 Japanese centers, 383 patients (mean age, 75.7  9.4
years) who required stent-graft landing in the aortic arch were treated with a precurved fenestrated endograft.
The device has 19 3-dimensional curved stent skeleton types similar to aortic arch configurations and 8 graft
fenestration types and is 24 to 44 mm in diameter and 16 to 20 cm long. The endografts were fabricated accord-
ing to preoperative 3-dimensional computed tomographic images.
Results: Technical and initial successes were achieved in 380 and 364 cases, respectively. Device proximal end
was at zones 0 to 2 in 363, 15, and 2 patients, respectively. Lesions’ proximal end ranged from zone 0 to 3 in 16,
125, 195, and 44 patients, respectively. The mean operative and fluoroscopic times were 161  76 and 26  13
min, respectively. The complications included stroke (7 patients), permanent paralysis (3), and perioperative
death (6). No branch occlusion or proximal migration of the device occurred during follow-up.
Conclusions:A precurved fenestrated endograft for endovascular repair in aortic arch disease rendered catheter
manipulation simple and minimized operative complication risks. Although most patients had inadequate prox-
imal landing zone and severely angled complex configuration, lowmortality and morbidity and satisfactory clin-
ical success were early outcomes, suggesting that this simplified treatment may be effective for aortic arch
disease. (J Thorac Cardiovasc Surg 2013;145:S103-9)As a less-invasive treatment, thoracic endovascular aortic
repair (TEVAR) has emerged over the last decade. TEVAR
for the descending thoracic aorta provides acceptable mid-
term morbidity and mortality.1,2 For aortic arch disease,
however, some challenges that relate to its angulated
morphologic features and the involvement of supra-aortic
branches still remain. In the mid-2000s in Japan, the pre-
curved fenestrated endograft Najuta (Kawasumi Lab, Inc,
Tokyo, Japan) was developed to achieve good conformabil-
ity and to extend the proximal landing zone. The multicen-
ter clinical trial for approval by the Japanese Ministry of
Health, Labor, andWelfare was conducted, with feasible re-
sults, in 2008 and 2009. In 2010, the multicenter clinical
study commenced in 35 Japanese hospitals with the latest
version of the Najuta graft, which is evolving continuously.
The aim of this study was to evaluate the results of our pre-
vious study on endovascular treatment with a precurvede Department of Cardiovascular Surgery, Tokyo Women’s Medical Univer-
okyo, Japan.
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The Journal of Thoracic and Cardfenestrated endograft for aortic arch disease and to explain
the advantages and limitations of this device.MATERIALS AND METHODS
Patients
From January 2010 to December 2011, a total of 383 patients at 35
Japanese centers who required stent-graft landing in the aortic arch under-
went endovascular repair with a fenestrated endograft (clinical use of this
device was approved by the individual institutional review board of each
hospital). There were 329 men and 54 women (mean age, 75.69  9.42
years; range, 23-93 years). All the patients were considered to have seri-
ous risk factors for open surgical repair and also to be ineligible for endo-
vascular repair with commercially available devices because of an
inadequate proximal landing zone. Of the patients, 332 had a degenerative
aneurysm, 44 had an aortic dissection, 5 had a traumatic transection of the
aortic isthmus, and 2 had a patent ductus arteriosus with congestive heart
failure.
Anatomic Indications
All the patients underwent preoperative contrast-enhanced multilayered
computed tomographic (CT) scans to assess the feasibility of endovascular
repair, sizing of the endograft, and implantation strategy. The aortic arch
configuration, including angulation and the location of branches and the
proximal sealing zone of the endograft, was evaluated by 3-dimensional
(3D) reconstruction with volume rendering of the CT data.
The anatomic exclusion criteria for endovascular aortic arch repair with
precurved fenestrated endograft were (1) proximal or distal landing zone
diameter greater than 42 mm; (2) all supra-aortic branches involved in
the aneurysmal wall; and (3) prohibitive occlusive disease, tortuosity, or
calcification of intended access vessels and angulation of the aorta that
would preclude advancement of the introduction system. In addition, an ad-
equate proximal sealing zone was required between the supra-aorticiovascular Surgery c Volume 145, Number 3S S103
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3D ¼ 3-dimensional
CT ¼ computed tomographic
LSA ¼ left subclavian artery
TEVAR ¼ thoracic endovascular repair04 The Jbranches and the lesion on the aortic wall. Theminimum length of that zone
depended on the morphology of the pathologic aortic arch (Figure 1).
Stent-Graft
A precurved fenestrated endograft was customized for each patient. This
device has 19 types of 3D curved stent skeletons and 8 types of graft fenestra-
tions for arch vessels. Those types of differently formed stent skeletons and
graft fenestrations were designed by analyzing more than 1000 clinical cases
of aortic arch endografting with a custom-made device. According to preop-
erative 3DCT, the endograft suitable for eachpatientwas fabricated by select-
ing from the available stent skeletons and graft fenestrations. The method of
devicedesign and the implantation strategyare represented inFigures 2 and 3.
The endograft ranged from 24 to 44 mm in diameter and 16 to 20 cm in
length. Commercially available devices (Excluder TAG; W.L. Gore &
Associates, Inc, Flagstaff, Ariz; and Zenith TX2; Cook Inc, Bloomington,
Ind) were used for the descending portion of the lesion as necessary.
Delivery System
This device has an original stabilizing system composed of rigid fixation
on the proximal tip and a traction suture to shrink the proximal end of the
stent-graft, for exact endograft positioning in the aortic arch under normal
blood pressure. During the deployment, the proximal end of the stent-graft
is gradually opened, and the second and third units of the Z-stent are landed
at the aortic wall first. The endograft is still amenable to fine adjustment at
this time. By making use of blood flow, the endograft can be pushed up to
the greater curvature to achieve good conformability to the aortic arch con-
figuration, and the graft material is expanded at the proximal landing zone
without touch-up ballooning. The details of this stabilizing system are ex-
plained in Figure 4.
To facilitate safe access to the ascending aorta, the delivery sheath has
a short, soft proximal tip and 3 types of precurved shapes similar to the aortic
arch. The outer diameter of the sheaths ranged from21F to 23F in the proximal
portion and tightened to 18F at the distal end. This characteristic formmay as-
sist precise deployment when the patient has a severely diseased access route.
Procedure
In 380 of the 383 patients, the endovascular procedure was performed
with general anesthesia, whereas epidural anesthesia was used in 3 patients.
The common femoral artery, exposed through an inguinal incision, was
mainly used as the access vessel. A ‘‘tug-of-wire’’methodwas the preferred
guiding technique used to stretch this precurved device in the access route.
The precurved fenestrated endograft was deployed in the aortic arch under
fluoroscopic guidance without additional circulatory support (ie, without
adenosine-induced cardiac arrest and rapid pacing).Device rotationwas au-
tomatically controlled by the precurved shape of the stent-graft and the ded-
icated stabilizingmechanism. Baseline digital subtraction angiographywas
performed before and after stent-graft deployment to confirm the proper po-
sitioning of the device and complete exclusion of the lesion (Figure 4).
Postdeployment balloon dilatation was performed selectively. Left sub-
clavian artery (LSA) revascularization was only undertaken in selected pa-
tients.3,4 Our selection criteria were (1) the coronary circulation suppliedournal of Thoracic and Cardiovascular Surby the LSA through the left internal thoracic artery, (2) an inadequate
contralateral vertebral artery, and (3) a high-risk for spinal cord ischemia.
RESULTS
The 383 patients who required stent-graft landing in the
aortic arch at zones 0 to 2 (the aortic arch map proposed
by Mitchell and colleagues5; Figure 5) were treated with
the precurved fenestrated endograft. The mean proximal
aortic diameter was 33.75  3.7 mm. The mean length of
the pathologic aortic arch was 79 57 mm (with the excep-
tion of aortic dissection of the double-barrel type). The
mean proximal sealing zone length was 14.3  5.3 mm.
Technical success, defined as successful deployment in
the intended location of the aortic arch, was achieved in
380 patients (99.2%), whereas in 3 patients the endograft
could not reach the thoracic lesion because of access vessel
inferiority. The proximal end of the device was placed at
zone 0 in 363 patients, zone 1 in 15, and zone 2 in 2. The
proximal end of the lesion originated in zone 0 in 16 pa-
tients, zone 1 in 125, zone 2 in 195, and zone 3 in 44
(Figure 5).
Initial success, defined as absence of type I or III endo-
leaks on postoperative CT scan, was obtained in 364 cases
(95.8%). The 30-day mortality was 1.6% (1 multiple em-
bolism, 1 fatal stroke, 1 ascending dissection, 1 respiratory
failure, 1 aneurysm rupture with type I endoleaks, and 1 un-
identified cause with impending rupture). Cerebrovascular
accident occurred in 7 patients (1.8%) and permanent pa-
ralysis in 3 (0.8%). Ascending aortic dissection occurred
in 3 patients: all had previous aortic dissection and
a large-diameter (40 mm) ascending aorta. One stent-
graft collapse occurred 4 days after the procedure in a pa-
tient with a small and tightly curved aortic arch. Three
open surgical replacements were performed, 2 in patients
with dissections and 1 in the patient with the stent-graft col-
lapse. Unanticipated chimney stenting6 was required to
preserve perfusion of supra-aortic trunks in 3 patients, in-
cluding 1 with a minor stoke.
Intentional coverage of the LSA was carried out in 298
patients with 17 simultaneous revascularizations. The
mean operative timewas 161 76 min (146 63 min with-
out LSA revascularization), and the mean fluoroscopic time
was 26  13 min.
DISCUSSION
A large number of thoracic pathologic conditions involve
the aortic arch, and operative approaches for aortic arch dis-
ease have therefore evolved continuously during the past 20
years. There have been significant developments in the
fields of surgical techniques and extracorporeal circulation;
nevertheless, conventional open aortic arch replacement is
still associated with substantial morbidity and mortality.7,8
In contrast, the endovascular approach has emerged during
the past decade as a valuable less-invasive treatment forgery c March 2013
FIGURE 1. A1, Preoperative 3-dimensional computed tomography (3D-CT) of a zone 1 aortic arch aneurysm with appropriate proximal landing zone and
short proximal sealing length (red line). A2, Postoperative 3-dimensional computed tomography with complete exclusion of the aortic arch aneurysm dem-
onstrates that the appropriate proximal landing zone provides good results. B1, Preoperative 3-dimensional computed tomography of a zone 1 aortic arch
aneurysmwith substantial proximal sealing length (red line) and inadequate proximal landing zone. B2, Postoperative 3-dimensional computed tomography
with complete exclusion of the aortic arch aneurysm demonstrates that the substantial proximal sealing length provides feasible results. C1, Preoperative
3-dimensional computed tomography of a zone 1 aortic arch aneurysmwith short proximal sealing length (red line) and inadequate (proximal diameter>40
mm) proximal landing zone. C2, Postoperative 3-dimensional computed tomography with type I endoleak (arrow) demonstrates blood flow into the lesion
through the posterior side of the stent-graft, causing insufficient contact between fenestrations and aortic wall.
Yokoi et al Panel 2descending thoracic aortic disease. Although some devices
that have recently been developed (eg, TX2 Pro-Form,
c-TAG) exhibit enhanced conformability to a curved config-
uration, the anatomic indications for aortic arch disease are
still limited by angulated complex morphological feature
and the involvement of supra-aortic branches. Hybrid proce-
dures involving open surgical debranching (which is per-
formed to provide an appropriate proximal landing zone for
the stent-graft and to preserve perfusion to the supra-aortic
trunks) followed by endovascular repair have therefore beenThe Journal of Thoracic and Cardapplied to patients who are poor surgical candidates
becauseof serious comorbidities.Recent reports havedemon-
strated the feasibility of aortic arch hybrid repair.9-12
It is possible that an entirely endovascular approach with
a branched or fenestrated endograftwould limit the operative
morbidity and mortality associated with the other options;
however, few studies13,14 have reported the use of branched
endografts for aortic arch disease. This is presumably
because of the difficulty involved in catheter manipulation
in the aortic arch, which increases the risk of emboliciovascular Surgery c Volume 145, Number 3S S105
FIGURE 2. A, Preoperative 3-dimensional computed tomographic (3D-CT) anteroposterior view of an aortic arch aneurysm with guiding red line used to
design proximal fenestrated stent-graft. B, Preoperative 3-dimensional computed tomographic left anterior oblique 30 viewwith guiding yellow line used to
design distal stent-graft. C, Head-to-foot view demonstrates complex configuration of the aortic arch aneurysm. D, The precurved fenestrated endograft
(proximal stent-graft) was fabricated by selecting from these kinds of 3-dimensional curved stainless stent skeleton and fenestrated expanded polytetra-
fluoroethylene grafts (e-PTFE). E, Distal stent-graft had a twisted formation similar to complicated configuration of this patient.
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FIGURE 3. Implantation strategy. A, Intraoperative digital subtraction
angiography before deployment of distal device. B, Intraoperative digital
subtraction angiography (DSA) after deployment of distal stent-graft,
which prevented migration of the proximal graft. C, Intraoperative digital
subtraction angiography after deployment of the proximal stent-graft
shows absence of endoleak. D, Postoperative 3-dimensional computed to-
mography (3D-CT) demonstrates that this device has good conformability
for the complicated configuration of this aortic arch aneurysm.
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The Journal of Thoracic and Cardstroke. In our study, the entirely endovascular procedurewith
a precurved fenestrated endograft simplified the
manipulation required, decreasing the incidence of
neurologic complications. Rotation of the device was
controlled by its precurved shape, which was designed to
be similar to the aortic arch configuration in each patient,
and the fenestrations were automatically oriented toward
the supra-aortic trunks. The short time required for operation
and fluoroscopy proves that this procedure does not entail
a complicated catheter technique. The high rate of clinical
success demonstrates that this endograft technique provides
an appropriate proximal landing zone across the supra-aortic
trunks and yields good conformability to aortic arch
angulations. Furthermore, a dedicated stabilizing mecha-
nismprovides precise endograft deploymentwithout circula-
tory assistance (eg, circulatory arrest induced by a drug and
rapid pacing) and minimizes contact between the supra-
aortic branch orifice and the ascending aortic wall. As
a result, although most patients in this study had inadequate
proximal landing zones and severely angled complex
configurations, low mortality and morbidity and a satisfac-
tory clinical success rate were achieved in the initial stage
of the study.
Long-term effectiveness could not be determined in this
early-stage study; however, the data from an earlier study
with the previous generation of precurved fenestrated endog-
rafts reportedbyKawaguchi andcolleagues15 and indicate ac-
ceptable midterm outcomes. Furthermore, the results of the
multicenter clinical trial (endografts implanted from 2008
to 2009, awaiting approval from the Japanese Ministry of
Health, Labor, and Welfare) confirmed midterm feasibility
with absence of proximal migration and branch occlusion.
The aimof surgical therapy for aortic pathologies is preven-
tion of aneurysm rupture, and the aim of the endovascular ap-
proach is tomake that surgery less invasive and safer. The aim
of our investigation is not only to extend anatomic indications
for treatment but also tominimize operative risks andmaintain
the activity of daily life of our patients such that they can con-
tinue to function normally for a substantial timewithout surgi-
cal intervention. In the near future in Japan, patients with
serious comorbidities (especially the elderly population) will
be treatedwith thisminimally invasive aortic repair technique,
as will the patients at lower risk with anatomic indications.
With constant development of the device and endograft
implant strategies, this simplified therapeutic method with
a precurved fenestrated endograft has the potential to be-
come one of the standard therapies for the treatment of aor-
tic arch disease.
CONCLUSIONS
A simplified arch aneurysm treatment with a precurved
fenestrated endograft represents a minimally invasive treat-
ment for aortic arch disease. The acceptable clinical success
and low incidences of stroke and early death, in conjunctioniovascular Surgery c Volume 145, Number 3S S107
FIGURE 4. A, The proximal tip has a concavity for fixation (top), and the proximal end of the stent-graft has a stainless steel hock (bottom). B, The prox-
imal end of the stent-graft is anchored to the tip (top), and the traction suture to shrink proximal end is fixed at distal end of the stent-graft (bottom). C, The
proximal end of the stent-graft is shrunk by traction suture (top), and the proximal end of the device is pulled down to a smaller coverture (bottom).
D, Predeployment digital subtraction angiographic (DSA) (top), intradeployment fluoroscopic (middle), and postdeployment digital subtraction angio-
graphic (bottom) images demonstrate precise deployment and exhibit device behaviors during the deployment period. E, As the traction suture is gradually
straightening during the stent-graft deployment, the proximal end of the stent-graft is gradually opening.
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FIGURE 5. The numbers of patients for proximal ends of the lesion and the stent-graft in anatomic zone mapping.
Yokoi et al Panel 2with the endovascular repair attained with this device, sug-
gest that it is potentially a valuable method for the treatment
of aortic arch disease. Further evaluation and follow-up are
still required, however, to determine the role that this endo-
vascular approach will have in the future.
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